Stock listing
MGNX Stock Price, News, Filings & Events — Macrogenics, Inc.
Selected listing: MGNX · BOATS · USD · US
This page tracks Macrogenics, Inc.'s MGNX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MGNX:BOATS. MGNX:BOATS is the stock-level entry point for investors researching Macrogenics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Macrogenics, Inc. (ticker: MGNX) is a public company based in America with a market capitalization of approximately $235.2 million. The company focuses on developing innovative therapies for cancer and other serious diseases. Macrogenics aims to advance its pipeline of biologic therapies to improve patient outcomes.
- Ticker
- MGNX:BOATS
- Asset type
- Stock
- Market cap
- $254.8M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BOATS
- Currency
- USD
Macrogenics, Inc. MGNX:BOATS stock context
This page tracks Macrogenics, Inc.'s MGNX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MGNX:BOATS. MGNX:BOATS is the stock-level entry point for investors researching Macrogenics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Macrogenics, Inc. (ticker: MGNX) is a public company based in America with a market capitalization of approximately $235.2 million. The company focuses on developing innovative therapies for cancer and other serious diseases. Macrogenics aims to advance its pipeline of biologic therapies to improve patient outcomes.
Latest news from Macrogenics, Inc.
MacroGenics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
September 9, 2026
MacroGenics Reports Second Quarter 2026 Financial Results, Streamlined Operating Model and Strengthened Financial Position
August 13, 2026
MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program
August 11, 2026
MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026
July 23, 2026
MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals
July 2, 2026
Macrogenics, Inc. earnings calls
MacroGenics, Inc. (MGNX) Q4 2024 Earnings Call
March 20, 2025 · Replay with transcript and chapters
MacroGenics, Inc. (MGNX) Q3 2024 Earnings Call
November 5, 2024 · Replay with transcript and chapters
MacroGenics, Inc. (MGNX) Q1 2024 Earnings Call
May 9, 2024 · Replay with transcript and chapters
MacroGenics, Inc. (MGNX) Q4 2023 Earnings Call
March 7, 2024 · Replay with transcript and chapters
MacroGenics, Inc. (MGNX) Q3 2023 Earnings Call
November 6, 2023 · Replay with transcript and chapters
MacroGenics, Inc. (MGNX) Q2 2023 Earnings Call
August 9, 2023 · Replay with transcript and chapters
Research Macrogenics, Inc.
Macrogenics, Inc. investor report
Review AI stock analysis and investor report context for MGNX:BOATS.
Macrogenics, Inc. company profile
View the public company page for Macrogenics, Inc. on 6ix.
Macrogenics, Inc. news
Read company news and market updates connected to Macrogenics, Inc..
Macrogenics, Inc. investor events
Find investor webinars, events, and replay context for Macrogenics, Inc..
Alternate listings
MGNX:NASDAQ
US · USD
Alternate listing for Macrogenics, Inc.; the primary context on this page is MGNX:BOATS.
M55:GETTEX
DE · EUR
Alternate listing for Macrogenics, Inc.; the primary context on this page is MGNX:BOATS.
A1W6ND:LSX
DE · EUR
Alternate listing for Macrogenics, Inc.; the primary context on this page is MGNX:BOATS.
A1W6ND:LS
DE · EUR
Alternate listing for Macrogenics, Inc.; the primary context on this page is MGNX:BOATS.
M55:TRADEGATE
DE · EUR
Alternate listing for Macrogenics, Inc.; the primary context on this page is MGNX:BOATS.
M55:BX
CH · CHF
Alternate listing for Macrogenics, Inc.; the primary context on this page is MGNX:BOATS.
M55:DUS
DE · EUR
Alternate listing for Macrogenics, Inc.; the primary context on this page is MGNX:BOATS.
M55:FWB
DE · EUR
Alternate listing for Macrogenics, Inc.; the primary context on this page is MGNX:BOATS.
M55:HAM
DE · EUR
Alternate listing for Macrogenics, Inc.; the primary context on this page is MGNX:BOATS.
M55:SWB
DE · EUR
Alternate listing for Macrogenics, Inc.; the primary context on this page is MGNX:BOATS.